Seeking Alpha

Arrowhead Research Corporation (ARWR)

  • IndyPEG | Send Message 18 Aug

    $ARWR taking $6 today?
    Reply (1)
    • matratra | Send Message 18 Aug
      : I like this security & may be near future it can go back to $10
      • StockConsultant | Send Message 12 Aug

        Stocks on breakdown watch: $KNDI $FUEL $ARWR and $OVAS
          • Kanak Kanti De | Send Message 6 Aug

            Arrowhead: Ignoring The Street Would Serve Investors Well $ARWR
              • Kanak Kanti De | Send Message 6 Aug

                Premarket Biotech Digest: My 2015 Biopicks, Arrowhead Conference Call, Earnings $ARWR
                  • beleggersclub | Send Message 5 Aug

                    8-6-2015 CHART OF THE DAY BUY $ARWR
                      • The Dutch Admiral | Send Message 5 Aug

                        Reading $ARWR Q3 2015 call, I feel a lot of excitement on their side. Sounds like they almost can't wait for next month' Analyst Day.
                          • vnmonk | Send Message 29 Jul

                            Harnessing the Power of RNAi Gene Silencing in Quest of Cure for Chronic Hepatitis B $ARWR
                              • Kanak Kanti De | Send Message 17 Jul

                                Market Continues To Underestimate The Potential Of Arrowhead's ARC-520 $ARWR
                                  • WItrader18 | Send Message 7 Jul

                                    Bought back $ARWR at $6.70 after selling at $7.20
                                    Reply (1)
                                    • matratra | Send Message 7 Jul
                                      : a great buy at this price.
                                      • SA Editor Mike Taylor | Send Message 6 Jul

                                        Premarket Biotech Digest: $ARWR's new trial, approval for $VRTX, insider sales
                                          Visit Seeking Alpha's
                                          ARWR vs. ETF Alternatives
                                          Company Description
                                          Arrowhead Research Corp is engaged in developing novel drugs to treat intractable diseases by silencing the genes. The Company's drug candidate ARC-520 is designed to treat chronic hepatitis B infection.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States